Integra LifeSciences Holdings (IART) Earnings Analysis

Integra LifeSciences Holdings (IART) next reports earnings on 2026-07-29, consensus EPS 0.48 USD. Last quarter (2026-02-26) it beat with EPS 0.83 USD vs 0.79 USD est (+5.1%). It has beaten estimates in 5/6 recent quarters (83%). Trailing P/E -2.90.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does IART next report earnings?

Next earnings date2026-07-29
Consensus EPS estimate0.48 USD
Revenue estimate0.42B

IART earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-02-260.83 USD0.79 USD+5.1%Beat
2025-10-300.54 USD0.43 USD+25.6%Beat
2025-07-310.45 USD0.43 USD+4.7%Beat
2025-05-050.41 USD0.43 USD-4.7%Miss
2024-11-040.41 USD0.39 USD+5.1%Beat
2024-07-290.63 USD0.62 USD+1.6%Beat

Beat rate: 5/6 (83%) over reported quarters with consensus data.

IART valuation and analyst view

Trailing P/E-2.90
Trailing EPS-6.44304 USD
Price / book1.39
Dividend yield0.00%
Market cap1.45B
Analyst consensusBuy (11 buy / 11 hold / 4 sell)
Avg price target21 USD

Related research pages

Frequently asked questions

When is Integra LifeSciences Holdings (IART)'s next earnings date?

Integra LifeSciences Holdings is next scheduled to report on 2026-07-29, with a consensus EPS estimate of 0.48 USD and revenue estimate of 0.42B.

Did IART beat earnings last quarter?

In its 2026-02-26 report, IART posted EPS of 0.83 USD versus a 0.79 USD estimate — a beat of 5.1%.

What is IART's earnings track record?

Over the last 6 reported quarters with consensus data, IART beat estimates 5 times (83%).

What is IART's current P/E ratio and EPS?

IART trades at a trailing P/E of -2.90 on trailing EPS of -6.443035178230303 USD.

What do analysts rate IART?

Analyst consensus is "Buy" across 26 ratings (0 strong buy, 11 buy, 11 hold, 4 sell, 0 strong sell). Average 12-month price target: 21 USD.